Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
29th Jul 202212:59 pmRNSNet Asset Value(s)
28th Jul 202212:18 pmRNSNet Asset Value(s)
27th Jul 202212:41 pmRNSNet Asset Value(s)
26th Jul 202212:01 pmRNSNet Asset Value(s)
25th Jul 20222:37 pmRNSGearing disclosure
25th Jul 202212:20 pmRNSNet Asset Value(s)
22nd Jul 202211:58 amRNSNet Asset Value(s)
21st Jul 202211:38 amRNSNet Asset Value(s)
20th Jul 202212:06 pmRNSNet Asset Value(s)
19th Jul 202212:27 pmRNSNet Asset Value(s)
18th Jul 20224:09 pmRNSGearing disclosure
18th Jul 202211:41 amRNSNet Asset Value(s)
15th Jul 202211:21 amRNSNet Asset Value(s)
14th Jul 20222:39 pmRNSPortfolio Disclosures
14th Jul 20221:07 pmRNSNet Asset Value(s)
13th Jul 202211:49 amRNSNet Asset Value(s)
12th Jul 202212:57 pmRNSNet Asset Value(s)
11th Jul 20222:04 pmRNSGearing disclosure
11th Jul 202212:23 pmRNSNet Asset Value(s)
8th Jul 202212:34 pmRNSNet Asset Value(s)
7th Jul 202212:46 pmRNSNet Asset Value(s)
6th Jul 20225:24 pmRNSMonth End Net Asset Value(s)
6th Jul 202212:42 pmRNSNet Asset Value(s)
5th Jul 202212:33 pmRNSNet Asset Value(s)
4th Jul 20225:38 pmRNSGearing disclosure
4th Jul 202212:39 pmRNSNet Asset Value(s)
30th Jun 202212:49 pmRNSNet Asset Value(s)
29th Jun 202212:46 pmRNSNet Asset Value(s)
28th Jun 202212:44 pmRNSNet Asset Value(s)
27th Jun 20223:48 pmRNSGearing Disclosure
27th Jun 202212:44 pmRNSNet Asset Value(s)
24th Jun 20221:04 pmRNSNet Asset Value(s)
24th Jun 202210:38 amRNSReplacement Third Interim Dividend
23rd Jun 20222:29 pmRNSThird Interim Dividend
23rd Jun 202212:05 pmRNSNet Asset Value(s)
22nd Jun 202212:47 pmRNSNet Asset Value(s)
21st Jun 202212:50 pmRNSNet Asset Value(s)
20th Jun 20224:47 pmRNSGearing disclosure
20th Jun 20221:37 pmRNSNet Asset Value(s)
17th Jun 202212:42 pmRNSNet Asset Value(s)
16th Jun 202212:16 pmRNSNet Asset Value(s)
15th Jun 20224:28 pmRNSPortfolio Disclosure
15th Jun 202212:28 pmRNSNet Asset Value(s)
14th Jun 202212:04 pmRNSNet Asset Value(s)
13th Jun 20222:52 pmRNSGearing disclosure
13th Jun 20221:12 pmRNSNet Asset Value(s)
10th Jun 202212:48 pmRNSNet Asset Value(s)
9th Jun 202212:27 pmRNSNet Asset Value(s)
8th Jun 20225:42 pmRNSMonth End Net Asset Value(s)
8th Jun 20221:18 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.